Ana Carolina Caballero Gonzalez

10PUBLICATIONS
42CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Automotive safety engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 01, 2025
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.

Anna Torrent, Mireia Morgades, Gloria Iacoboni

|Jan 22, 2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

Ana Carolina Caballero, Cristina Ujaldón-Miró, Paula Pujol-Fernández

|Apr 19, 2023
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Alberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro

|Mar 15, 2023
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Alberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro

Pageof 2